Document Detail


Safety and efficacy of laparoscopic adjustable gastric banding in patients aged seventy and older.
MedLine Citation:
PMID:  24582414     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Life expectancy is increasing, with more elderly people categorized as obese. The objective of this study was to assess the effects of laparoscopic adjustable gastric banding (LAGB) on patients aged ≥70 years.
METHODS: This was a retrospective analysis of patients aged ≥70 years who underwent LAGB at our university hospital between 2003 and 2011. The data included age, weight, body mass index (BMI), and percentage excess weight loss (%EWL) obtained before and after gastric banding. Operative data, length of stay, postoperative complications, and resolution of co-morbid conditions were also analyzed.
RESULTS: Fifty-five patients aged ≥70 years (mean 73 years) underwent gastric banding between 2003 and 2012. Mean preoperative weight and BMI were 123 kilograms and 45 kg/m(2), respectively. On average, each patient had 4 co-morbidities preoperatively, with hypertension (n = 49; 86%), dyslipidemia (n = 40; 70%), and sleep apnea (n = 31; 54%) being the most common. Mean operating room (OR) time was 49 minutes, with all patients discharged within 24 hours. There was 1 death at 4 years from myocardial infarction, no intensive care unit admissions, and no 30-day readmissions. Mean %EWL at 1, 2, 3, 4, and 5 years was 36 (±12.7), 40 (±16.4), 42 (±19.2), 41 (±17.1), 50 (±14.9), and 48 (±22.6), respectively. Follow-up rates ranged from 55/55 (100%) at 6 months to 7/9 (78%) of eligible patients at 5 years and 2/2 (100%) at 8 years. Complications included 1 band slip at year 5, 1 band removed for intolerance, and 1 port site hernia. The resolution of hypertension, dyslipidemia, sleep apnea, lower back pain, and non-insulin-dependent diabetes was 27%, 28%, 35%, 31%, and 35%, respectively.
CONCLUSIONS: LAGB as a primary treatment for obesity in carefully selected patients aged ≥70 can be well tolerated and effective with moderate resolution of co-morbid conditions and few complications.
Authors:
John J Loy; Heekoung A Youn; Bradley Schwack; Marina S Kurian; George A Fielding; Christine J Ren-Fielding
Related Documents :
24914374 - Changes in iron transporter divalent metal transporter 1 in proximal jejunum after gast...
10776714 - Toward a rational management of concomitant carotid and coronary artery disease.
3198974 - Carotid restenosis: should they all be reoperated on?
11845864 - Operative and 5-year outcomes of combined carotid and coronary revascularization: revie...
24030414 - Mitral valve disease in patients with marfan syndrome undergoing aortic root replacement.
8460964 - Immunoglobulin g immunosuppression of multiple sclerosis. suppression of all three majo...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-7-4
Journal Detail:
Title:  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery     Volume:  -     ISSN:  1878-7533     ISO Abbreviation:  Surg Obes Relat Dis     Publication Date:  2013 Jul 
Date Detail:
Created Date:  2014-3-3     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101233161     Medline TA:  Surg Obes Relat Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2014 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A systematic review of gastric plication for the treatment of obesity.
Next Document:  Hypertension remission 1 year after bariatric surgery: predictive factors.